Recursion's AI-designed cancer drugs REC-3565 and REC-617 show early clinical promise, with one patient responding unexpectedly well to treatment.

B stacks up against GPT-4o in practical tests. From coding to logic and creativity, here’s the side-by-side you’ve been ...